Canadian application, no grantCanada
Use of bupropion for the manufacture of a medicament for treating restless legs syndrome
CA 2494658 A1 · Owner: Robertson, David W. (Deceased) · Inventors: Robertson, David W. (Deceased)
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides for use of bupropion or a pharmaceutically acceptable salt thereof in the treatment of restless legs syndrome in humans.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 22, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 22, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 22, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 22, 2003
GrantedNo grant recorded
Term endedAugust 22, 2023
Patent numberCA 2494658 A1
Classification (IPC)A61K31/13 +1 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.